Immunohistochemical localization of cellular NFATc1 does not predict clinical responses to ciclosporin in subcutaneous panniculitis-like T-cell non-Hodgkin lymphoma.
Tauro
S
S
Maccallum
S
S
Groves
M J
MJ
Rojnuckarin
P
P
Assanasen
T
T
Feldman
A L
AL
Robson
A
A
Marschalkó
M
M
Kini
H
H
Alzolibani
A A
AA
Al Robaee
A
A
Al Shobaili
H A
HA
Alfawzan
S
S
Goodlad
J R
JR
Kernohan
N
N
Hummel
M
M
Sterry
W
W
Assaf
C
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016410:Lymphoma, T-Cell, Cutaneous / Q000737:chemistry / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D050778:NFATC Transcription Factors / Q000032:analysis*; D015434:Panniculitis / Q000188:drug therapy*; D055815:Young Adult
D014408:Biomarkers, Tumor; D007166:Immunosuppressive Agents; D050778:NFATC Transcription Factors; C494003:NFATC1 protein, human; D016572:Cyclosporine